In summary, we report for the first time that the mechanism by which bone marrow stromal cells induce resistance of CLL cells to ATO consists in activation of the PI3Kδ-PKCβ/NF-κB-STAT3/Mcl-1 pathways. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.